# I-MAB Biopharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/i-mab-biopharma

- Industry: Pharmaceuticals
- Headquarters: Rockville, US
- Website: www.i-mabbiopharma.com
- Total disclosed funding: $380M
- Latest round: Series C (Jun 29, 2018)
- Investors on record: 10

## About

Founded in 2014 and headquartered in Rockville, US, I-MAB Biopharma specializes in the R&D of precision immuno-oncology agents for the treatment of cancer. In January 2020, it was listed on NASDAQ under the ticker IMAB.  I-MAB Biopharma engages in the R&D of novel therapeutics across oncology, autoimmune disorders, and metabolic diseases. Its portfolio includes immunoglobulin Fc-fusion polypeptides for diabetes treatment, GLP-1 analogues for blood glucose reduction, and multiple immuno-oncology drug candidates aimed at enhancing cancer treatment outcomes. The company integrates in-house discovery with external partnerships to advance first-in-class and best-in-class biologics. The company generates revenue from collaborative licensing agreements, R&D partnerships, milestone payments, and future sales of proprietary biologic drug candidates.

## Funding rounds

- Series C, Jun 29, 2018, $220M — CDH Investments, Hony Capital, SG Growth Capital, Hopu Investment Management, Hillhouse Investment, Ally Bridge Group, CBC Group, Tasly Pharmaceutical Co., Ltd., Tally Capital
- Series B, Mar 23, 2017, $150M — CBC Group, Tasly Pharmaceutical Co., Ltd.
- Series A, Oct 19, 2016, $10M — I-Bridge Capital

## Investors

- I-Bridge Capital (https://capitalatlas.ai/funds/i-bridge-capital) — Series A
- CBC Group (https://capitalatlas.ai/funds/cbc-group) — Series B, Series C
- Tasly Pharmaceutical Co., Ltd. — Series B, Series C
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series C
- Hony Capital (https://capitalatlas.ai/funds/hony-capital) — Series C
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series C
- Hopu Investment Management — Series C
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series C
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series C
- Tally Capital (https://capitalatlas.ai/funds/tally-capital) — Series C